Commission Implementing Regulation (EU) 2018/1882 [Commission Implementing Regulation (EU) 2018/1882 of 3 December 2018 on the application of certain disease prevention and control rules to categories of listed diseases and establishing a list of species and groups of species posing a considerable risk for the spread of those listed diseases (OJ L 308, 4.12.2018, p. 21, ELI: http://data.europa.eu/eli/reg_impl/2018/1882/oj).] categorises each listed disease as a category A, B, C, D or E disease, which is subject to the corresponding disease-specific rules referred to in Article 9(1), points (a) to (e), of Regulation (EU) 2016/429. Implementing Regulation (EU) 2018/1882, as amended by Implementing Regulation (EU) 2026/169 [Commission Implementing Regulation (EU) 2026/169 of 26 January 2026 amending the Annex to Implementing Regulation (EU) 2018/1882 concerning the categorisation of infection with bluetongue virus (serotypes 1-24) as a listed disease (OJ L, 2026/169, 27.1.2026, ELI: http://data.europa.eu/eli/reg_impl/2026/169/oj).], categorises infection with bluetongue virus (serotypes 1-24) (‘infection with BTV’) as a category D+E disease. Implementing Regulation (EU) 2026/169 applies from 1 November 2026. However, before that amendment, Implementing Regulation (EU) 2018/1882 categorised infection with BTV as a C+D+E disease, and it was therefore subject to the disease-specific rules referred to in Article 9(1), points (c), (d) and (e), of Regulation (EU) 2016/429. As a result of that re-categorisation, the rules for infection with BTV concerning optional eradication programmes and disease-free status, laid down in Articles 2, 12, 37 to 45, 66, 70, 72 and 81 of Delegated Regulation (EU) 2020/689, and in Part II of Annex V thereto, are no longer relevant, as they only apply to category C diseases.
Recital 3, Regulation (EU) 2026/1215
In forcesince 11 Jun 2026